Market Insights

Equity Markets Immune to Delta Variant?

Equity markets largely shrugged off headline risks — the S&P 500 Index posted its seventh straight monthly gain.

Markets Moved Higher Despite Peak Concerns

July was, on balance, a good month for investors. Many broad market indexes across equity and fixed income posted positive returns.

Markets navigate an evolving inflation landscape

Global capital markets posted modest gains during May with value stocks outpacing their growth counterparts and international markets.

Economic momentum propels capital markets higher

U.S. business activity registered a substantial increase at the end of the first quarter of 2021. Find out why.

Economic activity accelerates heading into spring

March was another strong month for risk assets, especially in the U.S. as vaccine manufacturing and distribution ramped up.

Treasury volatility returns as stocks advance

Equities rallied, notably small cap and value stocks, amid more vaccine progress and the anticipation of more stimulus.

Optimism abounds

While we are constructive on near-term markets, we will focus on the rebound in business activity following progress with the vaccine.

A “Glass Half Full” Market

November displayed the forward-looking nature of markets as global equities reacted positively that a vaccine may be distributed in 2021.

Fiscal stimulus tricks, no treats for markets

Rising COVID-19 cases and a failure from policy makers to pass further fiscal stimulus weighed on equity markets.

Tech tumbled, ended risk asset rally

U.S. dollar strengthened in September as the existing monetary stimulus wane and expectations for fiscal stimulus before the election fade.